Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease hepatitis c
Phenotype C0019204|hepatocellular carcinoma
Sentences 124
PubMedID- 21278701 Conclusions: the incidence of hepatocellular carcinoma associated with hepatitis c infection decreased after 2001 in kyushu area.
PubMedID- 20458764 Aim: to elucidate the role of insulin resistance (ir) and serum adiponectin level in hepatocellular carcinoma (hcc) associated with chronic hepatitis c.
PubMedID- 20731020 hepatocellular carcinoma in patients with chronic hepatitis c virus infection without cirrhosis.
PubMedID- 23657093 Untreated chronic hepatitis c can lead to cirrhosis, hepatocellular carcinoma and death [2].
PubMedID- 25559606 The effect of hiv viral control on the incidence of hepatocellular carcinoma in veterans with hepatitis c and hiv coinfection.
PubMedID- 24037287 In fact, diverse studies have already correlated viral exposure to epigenetic alterations and human cancer such as hepatitis b virus and hepatitis c virus with hepatocellular carcinoma1626.
PubMedID- 26012225 This study elucidated the role of insulin resistance assessed by the homeostasis model (homa-ir) in development of hepatocellular carcinoma associated with chronic hepatitis c infection.
PubMedID- 21461077 Background/aims: despite great progress, antiviral treatment for chronic hepatitis c in patients with prior hepatocellular carcinoma (hcc) has been rarely investigated.
PubMedID- 22919246 A comparison of survival and pathologic features of non-alcoholic steatohepatitis and hepatitis c virus patients with hepatocellular carcinoma.
PubMedID- 25667487 Patients and methods: serum samples were collected preoperatively from 125 patients with hepatocellular carcinoma associated with hepatitis c virus infection who underwent curative hepatectomy.
PubMedID- 23509319 Statins and the risk of hepatocellular carcinoma in patients with hepatitis c virus infection.
PubMedID- 21499248 To identify the genetic susceptibility factor(s) for hepatitis c virus-induced hepatocellular carcinoma (hcv-induced hcc), we conducted a genome-wide association study using 432,703 autosomal snps in 721 individuals with hcv-induced hcc (cases) and 2,890 hcv-negative controls of japanese origin.
PubMedID- 22004425 Genetic risk of hepatocellular carcinoma in patients with hepatitis c virus: a case control study.
PubMedID- 23564522 The effects of interferon (ifn) treatment and the post-ifn treatment alpha-fetoprotein (afp) levels on risk of hepatocellular carcinoma (hcc) in patients with chronic hepatitis c (chc) are unknown.
PubMedID- 25469280 Dm with insulin resistance is a risk factor for hepatocellular carcinoma (hcc) in patients with hepatitis c virus (hcv) infection.
PubMedID- 21609495 Chronic hepatitis c viral infection can lead to cirrhosis and hepatocellular carcinoma [2].
PubMedID- 23701091 Objective: the objective of our study was to describe the cross-sectional imaging appearance of hepatocellular carcinoma (hcc) in patients with chronic hepatitis c virus (hcv) infection in the absence of advanced fibrosis and cirrhosis.
PubMedID- 21718500 Reported a correlation between a diabetic pattern of the 75 g oral glucose tolerance test ogtt and hepatocarcinogenesis and considered it a significant risk factor for hepatocellular carcinoma (hcc) in patients with hepatitis c virus [51].
PubMedID- 22410057 The primary liver diseases included hepatitis b virus (n=2), alcoholic liver cirrhosis (n=2), cryptogenic liver disease (n=1), and hepatitis c virus with hepatocellular carcinoma (n=1).
PubMedID- 23844083 Protein kinase r modulates c-fos and c-jun signaling to promote proliferation of hepatocellular carcinoma with hepatitis c virus infection.
PubMedID- 22555181 A critical evaluation of the preventive effect of antiviral therapy on the development of hepatocellular carcinoma in patients with chronic hepatitis c or b: a novel approach by using meta-regression.
PubMedID- 23404391 Repeat hepatectomies for hepatic malignant lymphoma and hepatocellular carcinoma associated with chronic hepatitis c: report of a case.
PubMedID- 23122451 Is serum level of methylated rassf1a valuable in diagnosing hepatocellular carcinoma in patients with chronic viral hepatitis c.
PubMedID- 22899800 A novel predictive score for hepatocellular carcinoma development in patients with chronic hepatitis c after sustained response to pegylated interferon and ribavirin combination therapy.
PubMedID- 23849467 The present cross-sectional study investigated 12 perfluoroalkyl substances (pfass) in serum (n=79) and liver (n=66) samples from patients who had undergone liver transplantation for a range of conditions, such as hepatocellular carcinoma (hcc), cirrhosis due to chronic hepatitis c viral infection (hcv), both hcc and hcv, amyloidosis or acute liver failure.
PubMedID- 25654412 Materials and methods: all patients who had undergone transplant for hepatocellular carcinoma associated with hepatitis c virus from 2002 to 2012 were evaluated retrospectively.
PubMedID- 22096937 [antiviral treatment reduces risk of hepatocellular carcinoma in patients with hepatitis c virus-related chronic hepatitis and cirrhosis].
PubMedID- 21129375 Maintenance peginterferon therapy and other factors associated with hepatocellular carcinoma in patients with advanced hepatitis c.
PubMedID- 22105231 Decrease in alpha-fetoprotein levels predicts reduced incidence of hepatocellular carcinoma in patients with hepatitis c virus infection receiving interferon therapy: a single center study.
PubMedID- 21619694 Similar findings have been reported in previous studies, including hepatocellular carcinoma associated with chronic hepatitis c, gastric carcinoma, and sporadic endometrial carcinoma [49,70,75], suggesting an interaction of mdm2 snp309, infectious factor, and hormone factor.
PubMedID- 23125843 The combined kir3ds1/hla-bw4-i80 genotype was also associated with decreased susceptibility for the development of hepatocellular carcinoma in patients with chronic hepatitis c virus (hcv; lopez-vazquez et al., 2005).
PubMedID- 21056500 The efficacy and safety of pegylated interferon plus ribavirin combination therapy in chronic hepatitis c patients with hepatocellular carcinoma post curative therapies - a multicenter prospective trial.
PubMedID- 21170963 Obesity and metabolic syndrome are recognized risk factors for development of hepatocellular carcinoma (hcc) in patients with chronic hepatitis c (chc).
PubMedID- 23065464 Data on the safety and efficacy of combination therapy in chronic hepatitis c patients with hepatocellular carcinoma (hcc) is scarce and even more so in hiv/hcv co-infected subjects.
PubMedID- 26305067 A variant in pnpla3 associated with fibrosis progression but not hepatocellular carcinoma in patients with hepatitis c virus infection.
PubMedID- 24662676 Given the role of hepatocellular cd81 in hcv infection and the association of chronic hepatitis c with hepatocellular carcinoma (hcc) there is a growing interest in studying the function of cd81 in hepatocytes.
PubMedID- 21520203 Occult hepatitis b virus infection and hepatocellular carcinoma development in patients with chronic hepatitis c.
PubMedID- 21537363 A 78-year-old male who experienced multiple recurrences of hepatocellular carcinoma (hcc) with hepatitis c virus (hcv)-related cirrhosis underwent transcatheter arterial chemoembolization and ablation and survived for more than 10 years.
PubMedID- 23497542 In japan, chronic hepatitis c is associated with 90% of hepatocellular carcinoma (hcc) cases, and hcc is associated with liver cirrhosis in 85% of all cases.
PubMedID- 24772876 [concurrent development of non-hodgkin lymphoma and hepatocellular carcinoma in patient with chronic hepatitis c].
PubMedID- 24463696 Influence of human t-lymphotropic virus type 1 coinfection on the development of hepatocellular carcinoma in patients with hepatitis c virus infection.
PubMedID- 26301052 hepatitis c infection can lead to cirrhosis and hepatocellular carcinoma and it is an important cause of mortality and morbidity.
PubMedID- 25544880 Evaluation of hepatocellular carcinoma development in patients with chronic hepatitis c by eob-mri.
PubMedID- 21234423 A 73-year-old female with history of hepatocellular carcinoma due to long-standing hepatitis c, presented to the emergency center with a sudden syncopal episode at home.
PubMedID- 22439008 [10] stated that phlebotomy therapy may potentially lower the risk of progression to hepatocellular carcinoma (hcc) in patients with hepatitis c virus infection.
PubMedID- 21563203 Inactivation of klf6 is common in hepatocellular carcinoma (hcc) associated with hepatitis c virus (hcv) infection, thereby abrogating its normal antiproliferative activity in liver cells.
PubMedID- 21224684 We performed transarterial chemoembolization (tace) on the 67-year-old man who had hepatectomy for hepatocellular carcinoma with hepatitis c, recurrence in the liver and lymph nodes.the metastasis in lymph node did not show a clear increase until dying, and tace showed the possibility of one treatment method to the metastasis in lymph node of the hepatocellular carcinoma.
PubMedID- 26446006 Background and objectives: we studied the effect of achieving sustained virological response (svr) on the risk of developing hepatocellular carcinoma (hcc) in patients with hepatitis c receiving anti-hepatitis c virus treatment.
PubMedID- 20981260 A 73-year-old man with a history of hepatocellular carcinoma associated with hepatitis c virus-related cirrhosis was referred to the department of urology because a thickened wall of the urinary bladder was incidentally detected by computed tomography (ct).
PubMedID- 21526141 We report a case of hepatocellular carcinoma (hcc) with chronic hepatitis c virus infection successfully treated with percutaneous radiofrequency ablation (rfa) under live four-dimensional (4d) echo guidance.

Page: 1 2 3